181 related articles for article (PubMed ID: 18573677)
1. Mechanism and treatment of dropped head syndrome associated with parkinsonism.
Oyama G; Hayashi A; Mizuno Y; Hattori N
Parkinsonism Relat Disord; 2009 Mar; 15(3):181-6. PubMed ID: 18573677
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor.
Wissel J; Masuhr F; Schelosky L; Ebersbach G; Poewe W
Mov Disord; 1997 Sep; 12(5):722-6. PubMed ID: 9380055
[TBL] [Abstract][Full Text] [Related]
3. Quantitative electromyographical changes in cervical dystonia after treatment with botulinum toxin.
Fuglsang-Frederiksen A; Ostergaard L; Sjö O; Werdelin L; Winkel H
Electromyogr Clin Neurophysiol; 1998 Mar; 38(2):75-9. PubMed ID: 9553744
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing the therapeutic effect of muscle afferent block for oromandibular dystonia and dyskinesia: implications for their distinct pathophysiology.
Yoshida K; Kaji R; Shibasaki H; Iizuka T
Int J Oral Maxillofac Surg; 2002 Oct; 31(5):499-505. PubMed ID: 12418565
[TBL] [Abstract][Full Text] [Related]
5. Parkinsonism and dropped head: dystonia, myopathy or both?
Savica R; Kumar N; Ahlskog JE; Josephs KA; Matsumoto JY; McKeon A
Parkinsonism Relat Disord; 2012 Jan; 18(1):30-4. PubMed ID: 21873101
[TBL] [Abstract][Full Text] [Related]
6. Effect of head rotation in whiplash-type rear impacts.
Kumar S; Ferrari R; Narayan Y
Spine J; 2005; 5(2):130-9. PubMed ID: 15749612
[TBL] [Abstract][Full Text] [Related]
7. Dropped head in Parkinson's disease.
Fujimoto K
J Neurol; 2006 Dec; 253 Suppl 7():VII21-26. PubMed ID: 17131224
[TBL] [Abstract][Full Text] [Related]
8. Reversible dropped head syndrome after hemispheric striatal infarction.
Funabe S; Tanaka R; Hayashi A; Yamashiro K; Shimura H; Hattori N
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):785-7. PubMed ID: 23800502
[TBL] [Abstract][Full Text] [Related]
9. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
[TBL] [Abstract][Full Text] [Related]
10. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part I): muscle afferent block versus botulinum toxin-A in cervical and limb dystonias.
Rosales RL; Santos MM; Ng AR; Teleg R; Dantes M; Lee LV; Fernandez HH
Int J Neurosci; 2011; 121 Suppl 1():35-43. PubMed ID: 21244305
[TBL] [Abstract][Full Text] [Related]
11. Hemibody mirror movements in hemiparkinsonism-hemiatrophy syndrome.
Silvers DS; Menkes DL
J Neurol Sci; 2009 Dec; 287(1-2):260-3. PubMed ID: 19766249
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
de Ru JA; Buwalda J
J Laryngol Otol; 2009 Apr; 123(4):412-7. PubMed ID: 18588738
[TBL] [Abstract][Full Text] [Related]
13. Muscle restricted vasculitis causing dropped head syndrome: a case report and review of the literature.
Nielsen AA; Smith BE; Engel AG; Bosch EP
J Clin Neuromuscul Dis; 2012 Mar; 13(3):117-21. PubMed ID: 22538306
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
Affaitati G; Fabrizio A; Savini A; Lerza R; Tafuri E; Costantini R; Lapenna D; Giamberardino MA
Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144
[TBL] [Abstract][Full Text] [Related]
15. [Cervical echomyography in cervical dystonia and its application to the monitoring for muscle afferent block (MAB)].
Mezaki T; Matsumoto S; Sakamoto T; Mizutani K; Kaji R
Rinsho Shinkeigaku; 2000 Jul; 40(7):689-93. PubMed ID: 11186906
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin B reduces sialorrhea in parkinsonism.
Racette BA; Good L; Sagitto S; Perlmutter JS
Mov Disord; 2003 Sep; 18(9):1059-61. PubMed ID: 14502678
[TBL] [Abstract][Full Text] [Related]
17. Myopathic dropped head syndrome: an expanding clinicopathological spectrum.
Liao JP; Waclawik AJ; Lotz BP; Salamat SM; Beinlich BR; Brooks BR
Am J Phys Med Rehabil; 2007 Dec; 86(12):970-6. PubMed ID: 18090438
[TBL] [Abstract][Full Text] [Related]
18. Dropped-head syndrome due to steroid responsive focal myositis: a case report and review of the literature.
Kastrup A; Gdynia HJ; Nägele T; Riecker A
J Neurol Sci; 2008 Apr; 267(1-2):162-5. PubMed ID: 17964603
[TBL] [Abstract][Full Text] [Related]
19. Dropped head syndrome: etiology and management.
Sharan AD; Kaye D; Charles Malveaux WM; Riew KD
J Am Acad Orthop Surg; 2012 Dec; 20(12):766-74. PubMed ID: 23203936
[TBL] [Abstract][Full Text] [Related]
20. Muscle afferent block for the treatment of oromandibular dystonia.
Yoshida K; Kaji R; Kubori T; Kohara N; Iizuka T; Kimura J
Mov Disord; 1998 Jul; 13(4):699-705. PubMed ID: 9686778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
